Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lassen

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 21, 2026
Gastropexy may reduce symptomatic recurrence in paraesophageal hernia repair: a Scandinavian retrospective multicenter studyLene Osterballe, Magnus H Fasting, Eirik K Aahlin, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 2020
Is there a role for the no observed adverse effect level in safety pharmacology?Tomas Mow, Ninette K Andersen, Nils Dragsted, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2011
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorderA Mørk, A Pehrson, L T Brennum, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 21, 2026
Gastropexy may reduce symptomatic recurrence in paraesophageal hernia repair: a Scandinavian retrospective multicenter studyLene Osterballe, Magnus H Fasting, Eirik K Aahlin, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 2020
Is there a role for the no observed adverse effect level in safety pharmacology?Tomas Mow, Ninette K Andersen, Nils Dragsted, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2011
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorderA Mørk, A Pehrson, L T Brennum, et al.
Pageof 6